Delivery Order HHSN271201100004I-HHSN27100015

This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health within the Department of Health and Human Services, to Pharmaron, Inc. for $64,090. The contract is for Pharmaron to conduct a 14-day dose range-finding toxicity study in male and female rats to determine the maximally tolerated dose of an investigational molecule under development by NCATS. Specifically, Pharmaron will test the...

This federal contract award to QPS LLC, a minority-owned limited liability company, is for the provision of rodent pharmacokinetic (PK) testing services to support the National Institute of Neurological Disorders and Stroke's (NINDS) Helping to End Addiction Long-term (HEAL) initiative. The $98,000.00 firm-fixed-price purchase order contract has a period of performance through September 22, 2025. The contract was competitively awarded and does not have a set-aside designation. The services to be...

This is a $129,586.25 firm fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Melior Discovery Inc. to provide continuous rodent and non-rodent pharmacokinetic assessment services. The contract was awarded under the NINDS Division Translational Research - Continuous Rodent and Non-Rodent Pharmacokinetic (PK) Assessments solicitation, which sought commercial sources with the capability to conduct routine rodent...

This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Pharmaron, Inc., a global contract research organization. The $281,751.22 purchase order contract is for a firm fixed price and does not have a set-aside designation. Under this contract, Pharmaron is conducting a variety of drug development activities to support the work of the NIH's National Center for Advancing Translational Sciences...

The Department of Health and Human Services National Center for Advancing Translational Sciences awarded a $19,504 firm-fixed-price purchase order to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems, to determine the pharmacokinetics in rats and dogs and conduct in vitro transporter studies for a novel drug compound. Absorption Systems is a global life science contract research organization that has provided testing services related to COVID-19 treatments and conducted...

This is a federal contract award from the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Battelle Memorial Institute. The $2,611,477.00 cost-plus-fixed-fee contract is for non-GLP dose-range finding and GLP toxicity studies in minipigs, as well as in vitro drug-drug interaction studies for a small peptide. The contract was awarded under the Manufacturing and Nonclinical Studies Support for the...

This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Pharmaron, Inc., a global contract research organization. The $87,805.00 firm fixed price contract was awarded as a delivery order under the NIH Bioanalysis Testing Services 2015-2020 master contract vehicle. Under this contract, Pharmaron conducted various drug development activities for NCATS, including...

This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The contract is valued at $24,320.00 and does not have a set-aside designation. The contract is for pharmacokinetic studies of two compounds in non-naive cynomolgus monkeys, using both oral and intravenous routes of administration, with bioanalyses in plasma conducted in triplicate. This...

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc., a global contract research organization (CRO) specializing in preclinical research services. The $10,656.00 contract is for a pharmacokinetic (PK) study in mice, with a final completion date of September 21, 2026. The work will be performed at Pharmaron's division in Louisville, Kentucky....

This is a firm fixed-price federal contract award from the U.S. Department of Veterans Affairs (VA) to Pharmaron, Inc., a minority-owned, for-profit contract research organization (CRO). The $86,400.00 contract is for an "INTRAVESICULAR TOXICITY AND TK STUDY" with a period of performance through March 31, 2016. The contract was awarded on August 27, 2015 and does not have a set-aside designation. Pharmaron has extensive expertise in preclinical drug development services, including...